FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Imprimis NJOF, LLC(080431967)" | Dorzolamide Hydrochloride | 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Dorzolamide Hydrochloride; Bimatoprost; Timolol Maleate | 20 mg/1 mL; .1 mg/1 mL; 5 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Dorzolamide Hydrochloride; Brimonidine | 20 mg/1 mL; 1.5 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Lidocaine Hydrochloride; Epinephrine Bitartrate | 7.5 mg/1 mL; .25 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Loteprednol Etabonate | 5 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | 4 mg/.8 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | .8 mg/.8 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | 4 mg/.8 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Bromfenac Sodium | 5 mg/1 mL; .75 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 5 mg/1 mL; 1 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 5 mg/1 mL; 10 mg/1 mL; .75 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Triamcinolone Acetonide | .6 mg/.6 mL; 9 mg/.6 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate | 1 mg/1 mL; 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 1 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 1 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Atropine Sulfate | .25 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Atropine Sulfate | .5 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Atropine Sulfate | .1 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Ondansetron Hydrochloride; Ketamine Hydrochloride; Midazolam | 2 mg/.165 g; 25 mg/.165 g; 3 mg/.165 g | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "Imprimis NJOF, LLC(080431967)" | Azithromycin Dihydrate | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-7084 | 71139-7084-2 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2025-2 | valid | 2026-10-06 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-7084 | 71139-7084-1 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2025-2 | valid | 2026-10-06 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5340 | 71139-5340-2 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/200 mL; 400 ug/200 mL | 2025-2 | valid | 2026-10-06 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5340 | 71139-5340-4 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/200 mL; 400 ug/200 mL | 2025-2 | valid | 2026-10-06 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5355 | 71139-5355-2 | Sugammadex | 200 mg/2 mL | 2025-2 | valid | 2026-10-06 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5355 | 71139-5355-1 | Sugammadex | 200 mg/2 mL | 2025-2 | valid | 2026-10-06 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-0190 | 71139-0190-1 | "vasopressin, Unspecified" | 2 U/2 mL | 2025-2 | valid | 2026-10-06 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-6030 | 71139-6030-1 | Fentanyl Citrate | 2500 ug/50 mL | 2025-2 | valid | 2026-10-06 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-0018 | 71139-0018-1 | Hydromorphone Hydrochloride | 20 mg/100 mL | 2025-2 | valid | 2026-10-06 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-0012 | 71139-0012-1 | Oxytocin | 30 U/500 mL | 2025-2 | valid | 2026-10-06 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-987 | 69374-987-50 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-984 | 69374-984-10 | Sodium Bicarbonate; Lidocaine Hydrochloride; Potassium Chloride | 1.04 g/1 mL; 123 mg/1 mL; 2.19 g/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-330 | 69374-330-05 | Albuterol | 5 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-946 | 69374-946-34 | Labetalol Hydrochloride | 5 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-988 | 69374-988-10 | Lysine Hydrochloride; Arginine Hydrochloride | 5000 g/1 mL; 5000 g/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "OSRX, Inc.(117108300)" | 83826-9057 | 83826-9057-2 | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "OSRX, Inc.(117108300)" | 83826-9065 | 83826-9065-0 | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "OSRX, Inc.(117108300)" | 83826-9076 | 83826-9076-5 | Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 25 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "OSRX, Inc.(117108300)" | 83826-9055 | 83826-9055-5 | Prednisolone Sodium Phosphate; Bromfenac Sodium | 10 mg/1 mL; .75 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "OSRX, Inc.(117108300)" | 83826-9033 | 83826-9033-5 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 10 mg/1 mL; 5 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "OSRX, Inc.(117108300)" | 83826-9018 | 83826-9018-5 | Bimatoprost; Timolol Maleate | .1 mg/1 mL; 5 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "OSRX, Inc.(117108300)" | 83826-9032 | 83826-9032-5 | Bimatoprost; Timolol Maleate; Dorzolamide Hydrochloride | .1 mg/1 mL; 5 mg/1 mL; 20 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "OSRX, Inc.(117108300)" | 83826-9003 | 83826-9003-5 | Bimatoprost; Timolol Maleate; Dorzolamide Hydrochloride; Brimonidine Tartrate | .1 mg/1 mL; 5 mg/1 mL; 20 mg/1 mL; 1 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "OSRX, Inc.(117108300)" | 83826-9006 | 83826-9006-5 | Timolol Maleate; Brimonidine Tartrate; Dorzolamide Hydrochloride | 5 mg/1 mL; 1 mg/1 mL; 20 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "OSRX, Inc.(117108300)" | 83826-9059 | 83826-9059-2 | Dorzolamide Hydrochloride; Brimonidine Tartrate | 20 mg/1 mL; 1 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "OSRX, Inc.(117108300)" | 83826-9066 | 83826-9066-5 | Dorzolamide Hydrochloride; Brimonidine Tartrate | 20 mg/1 mL; 1 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "OSRX, Inc.(117108300)" | 83826-9030 | 83826-9030-5 | Dorzolamide Hydrochloride; Brimonidine Tartrate; Bimatoprost | 20 mg/1 mL; 1 mg/1 mL; .1 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "OSRX, Inc.(117108300)" | 83826-9012 | 83826-9012-3 | Atropine Sulfate | .5 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "OSRX, Inc.(117108300)" | 83826-9080 | 83826-9080-1 | Moxifloxacin Hydrochloride | 1 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| "OSRX, Inc.(117108300)" | 83826-9034 | 83826-9034-5 | Moxifloxacin Hydrochloride; Bromfenac Sodium | 10 mg/1 mL; 75 mg/1 mL | 2025-2 | valid | 2026-10-06 |